AllianceBernstein’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
DIG
CCM
WVP
GCP
WAM
KCM
AllianceBernstein's GOSS Position: Q2 2026 in Review
AllianceBernstein sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 190,220 shares — an estimated $590K sold.
AllianceBernstein first reported a position in GOSS in Q1 2019 and held it in 23 quarters. The position peaked at $36M in Q2 2019. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.
- AllianceBernstein reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
- AllianceBernstein sold 190,220 Gossamer Bio shares in Q2 2026, an estimated $590K.
- AllianceBernstein first reported a position in Gossamer Bio in Q1 2019 and held it in 23 quarters.
- AllianceBernstein's Gossamer Bio position peaked at $36M in Q2 2019.
- 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.